VirExit Technologies Inc (OTCMKTS:VXIT) continues to move lower on Thursday. The stock has been under continous selling pressure over the past month with a fall of 67%.
Market Action
As of 10:04, VXIT stock fell 9% at $0.0130. The stock has traded 15.34 million shares, compared to its average volume of 39.92 million shares. The stock opened at $0.0142 and moved in a range of $0.0111 – 0.0143.
Major Trigger:
VirExit Technologies, Inc. Welcomes Dr. Michael Lewis, MD, MPH, MBA, FACPM, FACN To Advisory Board
Key Highlights:
- VirExit Technologies added Dr. Michael Lewis, MD, to the Advisory Board. Dr. Lewis’s experience in frontier sciences, patient care, integrative health, as well as his leadership roles in major health care organizations are a tremendous asset to the VirExit team.
- Dr. Lewis will focus his efforts working with the team on content, product reviews, and our whole health approach. He will assist in populating the SaferPlace Market with curated products focused on wellness, health, and safety.
- Headquartered in Richland, Washington, VirExit Technologies, Inc. is a fast-growing company focused on the wellness, health, and safety verticals for businesses and consumers. This approach is something we all need to be mindful of as we begin our return to work and normalcy in earnest.
- Michael D. Lewis, MD, MPH, MBA, FACPM, FACN, is an expert on nutritional interventions for brain health, particularly the prevention and rehabilitation of brain injury. He is a graduate of the U.S. Military Academy at West Point and Tulane University School of Medicine.
- Dr. Lewis is board-certified and a Fellow of the American College of Preventive Medicine and the American College of Nutrition. He completed post-graduate training at Walter Reed Army Medical Center, Johns Hopkins University, and Walter Reed Army Institute of Research.